Human Vaccines and Immunotherapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Knowledge mapping of B cell and atherosclerosis over the past 20 years: A bibliometric analysis
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 13, 2023 Category: Allergy & Immunology Authors: Tao ChengYaping YouBochao JiaHuan WangMeng LvXueping ZhuYuanhui Hua Department of Cardiological Medicine, China Academy of Chinese Medical Sciences Guang ’anmen Hospital, Beijing, Chinab Clinical Medicine School, Beijing University of Chinese Medicine, Source Type: research
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 10, 2023 Category: Allergy & Immunology Authors: Albert JangJake N. LichtermanJeffrey Y. ZhongJonathan E. ShoagJorge A. GarciaTian ZhangPedro C. Barataa Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USAb Division of Solid Tumor Oncology, Department of Medicine, Un Source Type: research
Identifying beliefs driving COVID-19 vaccination: Lessons for effective messaging
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 10, 2023 Category: Allergy & Immunology Authors: Sarah R. MacEwanEben KenahGraham N. DixonJack StevensLeanna Perez EitermanJonathan R. PowellChristopher B. GageLaura J. RushAshish R. PanchalAnn Scheck McAlearneya Division of General Internal Medicine, College of Medicine, The Ohio State University, Colu Source Type: research
Intraneural ganglion cyst of the peroneal nerve and coronavirus disease-19 vaccination: Relationship and possible mechanism
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 9, 2023 Category: Allergy & Immunology Authors: Somsri WiwanitkitViroj Wiwanitkita Private Academic and Editorial Consultant, Bangkok, Thailandb Center for Global Health Research Saveetha Medical College Saveetha Institute of Medical and Technical Sciences, India Source Type: research
COVID-19 vaccine hesitancy among pregnant women attending public antenatal clinics in Dar es Salaam, Tanzania
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 9, 2023 Category: Allergy & Immunology Authors: Zainab Hassan YussuphFadhlun M. Alwy Al-BeityFuraha AugustAmani Anaelia Department of Obstetrics and Gynecology, School of Medicine, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzaniab Department of Development Studies, Sc Source Type: research
“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 9, 2023 Category: Allergy & Immunology Authors: Monica Anne McArthurSiham BchirEstelle DuboisLucia GanEric GerchmanSandeep GuptaOlga LiabisLucia PerezFabienne RocheGustavo VasquezBetzana ZambranoSanjay GurunathanMandeep Singh Dhingraa Global Clinical Development Strategy, Sanofi, Swiftwater, PA, USAb G Source Type: research
Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 9, 2023 Category: Allergy & Immunology Authors: Samiyah AlshehriMalik Sallama Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabiab Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jor Source Type: research
Analysis of global research hotspots and trends in immune cells in intervertebral disc degeneration: A bibliometric study
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 9, 2023 Category: Allergy & Immunology Authors: Nan WangZehua MiShuang ChenXiaoyang FangZhipeng XiWenqiang XuLin Xiea Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. Chinab Hospital for Skin Diseases, Institute o Source Type: research
The association between influenza vaccination and the perception of COVID-19 as well as COVID-19 vaccination behavior among community residents in Anhui province, China
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 9, 2023 Category: Allergy & Immunology Authors: Mengjie GuoJian ’an LiYan WangGuimei ChenRen ChenLi Wanga School of Health Service Management, Anhui Medical University, Hefei, Anhui Province, Chinab Key Laboratory of Health Economics and Policy Research, National Health and Wellness Commission, Jinan Source Type: research
Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 8, 2023 Category: Allergy & Immunology Authors: Rose P. WebsterJordan A. MarckelAndrew B. NormanDepartment of Pharmacology & Systems Physiology, College of Medicine, University of Cincinnati, Cincinnati, OH, USA Source Type: research
The safety of BCG revaccination in the context of COVID-19
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 8, 2023 Category: Allergy & Immunology Authors: Adriana S ánchez-GarcíaReyes Támez-GuerraGerardo González-SaldivarRené Rodríguez-GutiérrezLuz Adriana Ramírez-GarcíaFrancisco J. BarreraJosé Gerardo González-Gonzáleza Endocrinology Division, Universidad Autónoma de Nuevo León, Facultad de M Source Type: research
Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 6, 2023 Category: Allergy & Immunology Authors: Aye MoaMohana KunasekaranZubair AkhtarValentina CostantinoC. Raina MacIntyrea Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australiab College of Public Service and Community Solutions, Arizona State University, Source Type: research
Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 6, 2023 Category: Allergy & Immunology Authors: Trevor ChristensenSherri ZornKathy BayKatherine TreendChrystal AveretteNicole Rhodesa Washington State Department of Health, Tumwater, Washington, USAb Washington State HPV Free Task Force, Tumwater, Washington, USA Source Type: research
Immunity to measles in COVID-19 era
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 3, 2023 Category: Allergy & Immunology Authors: Cristiana FerrariGiuseppina SommaLuca CoppetaDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy Source Type: research
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults
Volume 19, Issue 3, December 2023 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - November 3, 2023 Category: Allergy & Immunology Authors: Sylvie PichonFrancoise Guinet-MorlotJamshid SalehBrandon EssinkAndrea-Clemencia Pineda-Pe ñaAnnick MoureauCeline PetitAda-Maria Minutelloa Clinical Development, Sanofi, Marcy-l’Étoile, Franceb Research & Development, Sanofi, Marcy-l ’Étoile, Franc Source Type: research
